| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 282,244 | 212,178 | 246,639 | 247,211 | | Cost of Revenue | 136,030 | 107,459 | 120,897 | 118,829 | | | Gross Profit | 146,214 | 104,719 | 125,742 | 128,382 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 68,025 | 61,891 | 61,468 | 55,002 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 78,189 | 42,828 | 64,274 | 73,380 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,769 | 3,626 | 3,331 | 2,161 | | Earnings Before Interest And Taxes | 80,958 | 46,454 | 67,605 | 75,541 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 80,958 | 46,454 | 67,605 | 75,541 | | Income Tax Expense | 30,726 | 17,643 | 22,505 | 29,744 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 50,232 | 28,811 | 45,100 | 45,797 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 50,232 | 28,811 | 45,100 | 45,797 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $50,232 | $28,811 | $45,100 | $45,797 |
|
1.49% Nasdaq 
0.27%
Income Statement
